Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
China flag China · Delayed Price · Currency is CNY
2.900
-0.030 (-1.02%)
Aug 4, 2026, 3:00 PM CST

SHA:603718 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
173.47187.87271.04240.72299.99347.29
Revenue Growth
-33.92%-30.69%12.59%-19.76%-13.62%34.02%
Gross Profit
119.61135.9160.65120.42175.38188.89
Operating Income
36.2745.0518.53-6.515.6921.9
Net Income
-316-311.44171.1862.87121.6153.86
Earnings Per Share
-0.47-0.480.260.100.190.08
EPS Growth
--160.00%-47.37%137.50%700.00%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
Veterinary Biological Products
62.39
Medical Instruments
125.48
Total
187.87

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
387.72425.14517.08353.22392.71538.63
Total Debt
90.9516.8117.6271.02158.12477.66
Net Cash (Debt)
296.77408.34499.4982.2234.5960.97
Net Cash Growth
-35.35%-18.25%507.66%-64.96%284.77%13.27%
Net Cash Per Share
0.440.630.760.130.370.09

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
68.1158.8346.47-8.37292.9143.63
Capital Expenditures
-8.96-12.17-8.39-7.81-19.85-37.78
Free Cash Flow
59.1646.6638.08-16.18273.065.85
Free Cash Flow Growth
71.84%22.53%--4564.07%-95.62%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
68.95%72.34%59.27%50.02%58.46%54.39%
Operating Margin
20.91%23.98%6.84%-2.70%5.23%6.30%
Pretax Margin
-113.37%-98.37%76.78%23.27%43.74%16.45%
Profit Margin
-182.17%-165.77%63.16%26.12%40.54%15.51%
FCF Margin
34.10%24.84%14.05%-6.72%91.02%1.69%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
0.078-0.0780.0290.057
Dividend Per Share Growth
173.17%-173.17%-49.38%-
Dividend Yield
2.70%-1.15%0.27%0.59%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--26.56112.0752.00182.95
Forward PE
-81.1981.1981.1981.1981.19
P/FCF Ratio
31.9685.71119.37-23.161683.00
PS Ratio
10.9021.2916.7729.2721.0828.37